Amorepacific Corporation (KRX:090430)

Revance Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,134,826	6,461,331	8,864,485	8,545,398	10,540,669	12,591,777
Market Cap Growth	-15.98%	-27.11%	3.73%	-18.93%	-16.29%	0.47%
Enterprise Value	7,697,010	6,304,217	8,203,210	7,898,849	9,852,688	12,255,386
Last Close Price	131500.00	103695.03	143471.18	135151.16	163358.39	200389.10
PE Ratio	16.97	12.86	49.22	63.55	54.42	358.41
Forward PE	25.24	20.71	34.21	43.49	28.39	41.65
PS Ratio	2.01	1.66	2.41	2.07	2.17	2.84
PB Ratio	1.51	1.21	1.82	1.79	2.22	2.82
P/TBV Ratio	2.31	1.86	1.95	1.92	2.31	2.96
P/FCF Ratio	24.82	25.49	41.48	165.58	17.56	33.91
P/OCF Ratio	20.25	19.32	25.46	56.58	15.25	22.71
PEG Ratio	-	0.15	0.15	0.15	0.18	0.74
EV/Sales Ratio	1.90	1.62	2.23	1.91	2.03	2.77
EV/EBITDA Ratio	8.62	13.19	22.79	15.71	13.97	20.37
EV/EBIT Ratio	12.32	28.59	75.83	36.87	28.70	85.70
EV/FCF Ratio	23.49	24.87	38.39	153.05	16.42	33.00
Debt / Equity Ratio	0.08	0.08	0.07	0.08	0.08	0.09
Debt / EBITDA Ratio	0.76	0.92	0.97	0.71	0.55	0.70
Debt / FCF Ratio	1.23	1.74	1.64	6.92	0.65	1.13
Asset Turnover	0.63	0.61	0.63	0.69	0.82	0.76
Inventory Turnover	2.72	2.55	2.88	2.97	3.00	2.92
Quick Ratio	1.14	1.06	1.71	1.47	1.26	1.36
Current Ratio	1.63	1.58	2.40	2.06	1.74	1.89
Return on Equity (ROE)	12.49%	11.80%	3.60%	2.71%	3.93%	0.49%
Return on Assets (ROA)	2.58%	2.17%	1.16%	2.25%	3.63%	1.53%
Return on Capital (ROIC)	3.00%	2.51%	1.31%	2.61%	4.28%	1.80%
Return on Capital Employed (ROCE)	4.60%	3.90%	2.10%	4.30%	6.90%	3.00%
Earnings Yield	6.57%	9.18%	2.03%	1.57%	1.84%	0.28%
FCF Yield	4.03%	3.92%	2.41%	0.60%	5.69%	2.95%
Dividend Yield	0.86%	1.08%	0.63%	0.50%	0.60%	0.40%
Payout Ratio	10.09%	10.64%	26.12%	50.68%	28.31%	195.06%
Buyback Yield / Dilution	0.06%	0.07%	-0.04%	-0.40%	-0.32%	0.19%
Total Shareholder Return	0.89%	1.16%	0.59%	0.11%	0.28%	0.59%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.